DOSTARLIMAB
dostarlimab 500 mg/10 mL injection, 10 mL vial
DOSTARLIMAB (14133W)
14133W
Manner of administration:Injection
Restriction (Streamlined authority code: 15163)
Indication: Advanced, metastatic or recurrent endometrial carcinoma
Treatment phase: Initial treatment covering the first 6 treatment cycles
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 500 mg | # of repeats: 5 | DPMA: $7,891.47 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Jemperli
(dostarlimab 500 mg/10 mL injection, 10 mL vial)
|
||||
